Veracyte Inc

2026. g. 24. aug. 19:36 UTC

Veracyte Inc shares declined during Monday's session, reflecting broader trends in the genomics sector and a notable drop in the ARK Genomic Revolution ETF.

2026. g. 20. aug. 20:06 UTC

Shares lower amid declines in SPDR S&P Biotech ETF.

2026. g. 19. aug. 19:31 UTC

Veracyte Inc shares are higher, supported by a notable increase in the ARK Genomic Revolution ETF and positive trends in the biotechnology sector.

2026. g. 18. aug. 23:36 UTC

Veracyte Inc shares are higher in after-market hours, reaching a peak above Tuesday's close. The stock remains significantly lower compared to last month.

2026. g. 17. aug. 20:06 UTC

Veracyte Inc is higher as the Biotechnology sector advances, with increased trading volume reflecting heightened investor interest. The stock earlier pulled back from session highs.

2026. g. 14. aug. 20:06 UTC

Veracyte Inc's shares are lower today, reversing from recent gains amid broader market concerns following a reported decline in U.S. retail sales for July.

2026. g. 13. aug. 19:51 UTC

Veracyte Inc shares are lower today, breaking a trend of higher closes. No specific news was identified for this decline amid notable market volume.

2026. g. 12. aug. 20:01 UTC

Veracyte Inc shares are lower today, following a broader market decline. The stock remains significantly below its 20-day moving average.

2026. g. 11. aug. 19:26 UTC

Veracyte Inc reported second-quarter revenue of $150.32 million and raised its 2026 outlook to $590 million to $596 million, boosting shares higher.

2026. g. 10. aug. 19:36 UTC

Veracyte Inc shares declined Monday, trading lower since Friday's close amid broader market volatility and rising oil prices affecting inflation expectations.

2026. g. 7. aug. 19:26 UTC

Veracyte Inc shares are higher, supported by a rise in the ARK Genomic Revolution ETF and broader small-cap strength from the Russell 2000 Index.

2026. g. 6. aug. 19:26 UTC

Veracyte Inc shares are higher today, despite earlier losses. No specific news was identified to explain the price movement during the session.

2026. g. 5. aug. 19:32 UTC

Veracyte Inc's shares are lower, reflecting broader market sentiment amid recent crude oil price declines. Trading volume is unusually high today.

2026. g. 4. aug. 19:36 UTC

Veracyte shares are rising as Piper Sandler and Stephens maintain Overweight ratings, despite lowering price targets to $54 and $55, respectively.

2026. g. 3. aug. 20:06 UTC

Veracyte Inc's shares are lower today, diverging from broader market gains amid high trading volume. No specific news was identified to explain the decline.

2026. g. 1. aug. 00:01 UTC

Veracyte Inc is trading lower in after-market hours, reflecting broader market declines. Shares remain near the lower end of their one-month range.

2026. g. 31. jūl. 20:02 UTC

Veracyte Inc shares are lower despite positive analyst outlooks and target increases from Freedom and Needham following a recent earnings report that exceeded expectations.

2026. g. 30. jūl. 23:21 UTC

Veracyte shares fell in after-market trading despite reporting second-quarter revenue of $150.3 million and adjusted EPS of $0.54, exceeding expectations.

2026. g. 29. jūl. 19:47 UTC

Veracyte Inc's shares are advancing as the Federal Reserve maintains interest rates. The decision aligns with market expectations amid ongoing economic expansion.

2026. g. 28. jūl. 15:22 UTC

Veracyte Inc. shares are higher today, supported by broader strength in biotechnology stocks. No specific news was identified to explain the price movement.

2026. g. 27. jūl. 20:14 UTC

Veracyte Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment may be affected by declining crude oil prices.

2026. g. 24. jūl. 22:16 UTC

Veracyte Inc shares declined during after-market hours, reflecting broader weakness in the biotechnology sector. The stock shifted toward the lower end of its one-month trading range.

2026. g. 22. jūl. 20:13 UTC

Veracyte Inc shares are lower in after-market trading, reflecting broader market declines amid rising crude oil prices and geopolitical tensions.

2026. g. 21. jūl. 17:16 UTC

Veracyte Inc shares are higher today, recovering after three days of declines. The stock is now above its 20-day moving average.

2026. g. 20. jūl. 20:01 UTC

Veracyte Inc shares declined sharply today, marking three consecutive lower sessions amid broader market weakness and heightened volatility related to geopolitical tensions.